ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

SUP Supreme Plc

166.00
2.00 (1.22%)
20 Sep 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Supreme Plc LSE:SUP London Ordinary Share GB00BDT89C08 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  2.00 1.22% 166.00 162.00 170.00 166.00 166.00 166.00 85,189 08:00:26
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Household Appliance Stores 155.61M 11.97M 0.1026 16.18 191.24M
Supreme Plc is listed in the Household Appliance Stores sector of the London Stock Exchange with ticker SUP. The last closing price for Supreme was 164p. Over the last year, Supreme shares have traded in a share price range of 87.50p to 209.00p.

Supreme currently has 116,611,033 shares in issue. The market capitalisation of Supreme is £191.24 million. Supreme has a price to earnings ratio (PE ratio) of 16.18.

Supreme Share Discussion Threads

Showing 426 to 447 of 1375 messages
Chat Pages: Latest  19  18  17  16  15  14  13  12  11  10  9  8  Older
DateSubjectAuthorDiscuss
25/4/2022
14:19
He mentioned a 4.6% dividend. So we are looking at a 5p final divi sometime?
ramellous
24/4/2022
08:00
This is from Javed Khan who has been asked by Sajid Javid, the Health Secretary, to conduct an independent review on how England will meet its target of reducing smoking prevalence to below 5pc by 2030.
actscap
24/4/2022
07:58
E-cigarettes are likely to be a central plank of Mr Khan's proposals, despite some uncertainty over their long-term effects.He said: "I'm seriously looking at the possible promotion of vaping as a less harmful alternative to cigarettes. Because the bulk of evidence around the world is pretty clear that vaping is significantly less harmful. There are some people who disagree with that, but the vast majority don't."So there seems to be a strong case for the promotion of vaping, even potentially medicinally licensed vaping. So vaping on prescription, why not?" Source: https://www.telegraph.co.uk/business/2022/04/23/big-tobacco-slapped-700m-tax-ease-nhs-smoking-burden/
actscap
23/4/2022
12:44
https://www.equitydevelopment.co.uk/hubfs/Research/Supreme/Supreme%20plc%20%20%2012%20April%202022.pdfSupreme plc (Listing AIM, Market Cap £188m)Trading Update - growth propelled by Vaping In a Trading Update for the year to 31 March 2022, Supreme PLC reports that it expects revenue of above £130.0m and EBITDA (adjusted) of no less than £21.0m based on strong organic growth in its core segments, augmented by strategic acquisitions. The Group expects continued profitable growth in FY23 driven by demand for its Vaping division products, partially offset by commodity price inflation impacting Sports Nutrition & Wellness division. The update indicates FY22 performance in line with our forecasts; our revenue estimate of £130.0m is revised to £130.4m. We have revised EBITDA outlook from £21.5m to £21.2m to reflect the impact of commodity price inflation in the Sports Nutrition & Wellness segment (12.1% of FY22 estimated revenue). Vaping remains the mainstay of performance, where Supreme expects to report 10%YoY growth in FY22 (33.4% of ED estimated revenue: 52.8% of ED estimated gross contribution) backed by the addition of Sainsbury's and Morrisons to its customer base. The Group highlights 2%YoY growth in the Batteries division (26.4% of FY22E revenue) and +5%YoY in Lighting (20.9% of FY22E revenue) with gross margin improvement.For FY23 Supreme highlights "double digit" growth prospects in its Vaping division. Despite FY22 growth in Sports Nutrition & Wellness revenue of over 130%YoY(E), profitability in this division was impacted by a combination of the increased price of whey and additional wage and transportation costs.We remain fundamentally positive for growth prospects in Supreme's leading Vape division where we expect the contribution to gross earnings to have risen from 45.1% in FY20 to just under 60% by FY24, propelling an increase in total (pre-forex) gross margin from 28.0% to 30.5% over the period.Our positive outlook for Vaping offsets near-term pressure on the Sports Nutrition & Wellness segment so that our revenue outlook to FY24 is unchanged. Our FY23 EBITDA (adj.) outlook is £22.0m from £24.0m, an 8.2% reduction, and in FY24 6.6% lower, taking a conservative view on the medium-term trends in energy and commodity prices which have already impacted a broad range of sectors. Taking these factors into account we adjust our fair value to 230p/share.
tole
23/4/2022
11:26
The whey powder products are sold at 12-15 quid. Everything else Supreme are selling are at much lower price points with 3-4% or 4-5% increases. So they are passing on these smaller increases as it's a small %age of a small price.

But for the powder products, they are considerably more expensive already. And the %age price increases are more significant. So they can pass on some of the increase, but passing it all on would certainly mean loss of sales as getting folk to shell out 12-15 quid is already much harder than buying the much cheaper products. Increase those powders to 20 quid selling price and you've lost customers.

They're building the business and market share and so are taking a temporary hit on the margins of whey powder products. Important to know that it's temporary. And I kind of feel they're looking at the worst case scenario as they're buying as much as they can in advance.

And when the prices come down, the business immediately benefits, before forecasts get revised, which will result in 'beating expectation' type trading updates.

dougmachin
23/4/2022
09:41
The view was it was more difficult in the wellness area as you miss the key price points, but in other areas costs increases are being passed on.
topvest
22/4/2022
21:49
Any comments please on just increasing price? Seems the simplest way to maintain margins
shanklin
22/4/2022
20:24
Yes, thanks - I watched and was reasonably reassured. It's a difficult time for any business, but the CEO here is going to be a big success medium to long term. Looking forward to the ride over the next 10 years!
topvest
22/4/2022
17:21
Thanks for the update - really useful.
actscap
22/4/2022
17:00
Thanks for the update much appreciated.
boonboon
22/4/2022
16:23
Yes, short presentation followed by several questions.

No real revelations but a random selection of my notes

£16m wellness rev (up from £7m), Sea Lions going well (Pet range next), Millions only Ok. Q4 margin compressed due to Whey Protein.

Vaping growth at 10% obscures higher growth in bulk of business (HMPPS & Online growth lower) Morrisons added Jan 22 and new innovations being progressed.

M&A likely in Vaping and Wellness. Planning to spend the new £25m RCF. Suspect the price of Whey will break some competitors and lead to cheap acqs.

Mentioned international plan in lighting. Vaping too difficult due to changing regulations in individual countries.

FY22 numbers - comfortable and conservative. M&A likely to make them obsolete.

cockerhoop
22/4/2022
16:01
Did anyone listen to the presentation?
boonboon
21/4/2022
14:14
Nice tick up on decent volume. IMC presentation tomorrow...
johndoe23
14/4/2022
13:08
I have registered - should be interesting.
topvest
14/4/2022
12:22
Yep, definitely worth tuning in for.
dougmachin
14/4/2022
12:05
#SUP - save the date! 22nd April Investor Presentation post recent Trading Update

Supreme (AIM:SUP), a leading manufacturer, supplier and brand owner of fast-moving consumer products, will be conducting an Investor Presentation webinar following the recent publication of their Trading Update for the 12 months ended 31 March 2022.

The presentation will be hosted by Sandy Chadha, CEO, and Suzanne Smith, CFO.

The event will take place at 12.00pm on Friday 22nd April.

The online presentation is open to all existing and potential shareholders. Questions can be submitted during the presentation to be addressed at the end.

Register here:

edmonda
13/4/2022
16:17
These are looking quite attractive on a forward P/E of 11.5. Forecasts were maintained at 12.6p EPS for FY22 and a 6.6p DPS. Next year, forecasts were reduced from 14.3p EPS to 13.6p EPS and a 7.3p EPS. So, the froth has come off Supreme as its no longer thought of as a growth share because it might have a flat year. This is the market for you. Of course its a growth share medium term. Some good top-up opportunities may be available as the traders move elsewhere.
topvest
13/4/2022
11:23
well I've added a few more at 152.5p, might be premature who knows ??
danb45
12/4/2022
16:02
Can't say I agree with that. Its about gaining market share in a fast growing sector.The prize is big and its worth the short term pain.
miti 1000
12/4/2022
15:25
Yep, a pretty generous interpretation of SUP apparently not having pricing power. Just amazed they haven't already pushed through price increases... ...or at least committed to pushing them through shortly.
shanklin
12/4/2022
15:17
pretty positive interpretation of todays SUP results - basically gets a thumbs up ??
danb45
12/4/2022
15:08
Both brokers have SUP as a buy, target price of 230p.

Berenberg Bank - Owen Shirley
Equity Development Limited - Andy Brown

From their previous 240p / 250p.

So, from this point, share price has a potentially bigger upside compared to yesterday!

dougmachin
Chat Pages: Latest  19  18  17  16  15  14  13  12  11  10  9  8  Older

Your Recent History

Delayed Upgrade Clock